Comparison between PET and PET/CT in recurrent head and neck cancer and clinical implications.
about
Diagnosis and treatment of recurrent laryngeal cancer following initial nonsurgical therapy.The use of examination under anaesthesia and panendoscopy in patients presenting with oral cavity and oropharyngeal squamous cell carcinoma.Early detection in head and neck cancer - current state and future perspectives.Early detection of recurrent disease by FDG-PET/CT leads to management changes in patients with squamous cell cancer of the head and neck.Inter-observer agreement improves with PERCIST 1.0 as opposed to qualitative evaluation in non-small cell lung cancer patients evaluated with F-18-FDG PET/CT early in the course of chemo-radiotherapy.Integrated FDG PET/CT: Utility and Applications in Clinical Oncology.Detecting Residual/Recurrent Head Neck Squamous Cell Carcinomas Using PET or PET/CT: Systematic Review and Meta-analysis.2-Deoxy-2[F-18]FDG-PET for detection of recurrent laryngeal carcinoma after radiotherapy: interobserver variability in reporting.Improvement in the detection of locoregional recurrence in head and neck malignancies: F-18 fluorodeoxyglucose-positron emission tomography/computed tomography compared to high-resolution contrast-enhanced computed tomography and endoscopic examinatAHNS Series: Do you know your guidelines? Evidence-based management of oral cavity cancers.Qualitative interpretation of PET scans using a Likert scale to assess neck node response to radiotherapy in head and neck cancer.A Score-Based Approach to 18F-FDG PET Images as a Tool to Describe Metabolic Predictors of Myocardial Doxorubicin Susceptibility.Role of panendoscopy in identifying and managing risk of head and neck squamous cell carcinoma in routine follow-up: a retrospective clinical evaluation.Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
P2860
Q33870104-3BE02CE6-6957-4655-9C91-262614C4DFCBQ34251725-8416BD1A-2987-467D-8B38-F2ADFD1056FAQ35427604-60540F26-587C-45B0-B82D-BBCABEF9F2A2Q37247189-48B0586C-654B-4822-8D68-161B1BE2282EQ37273224-112072FA-6F26-4EDE-9745-AA044F161DC4Q38260852-464F1578-7BC2-454F-8AA3-E10A8DA40980Q38682649-1F963730-81E4-4721-9F34-9E71E6E462BDQ42394201-F7282746-4145-4F14-A0D7-6013137DC524Q44791637-75D7700F-75D3-4D97-961F-11EC6F661A81Q46796923-4C287E78-A238-484A-8DAA-475685C0F333Q48125466-438F5AA6-E9D5-464E-978F-9F46DE2D5C3FQ49356783-23BA5EDF-2F5B-45DF-99FC-2D489BE2ECD5Q50672447-B1491784-8310-4E42-AD69-1F487D331455Q50950243-EC056974-A922-42AC-8212-A3BB8C0ED3F8
P2860
Comparison between PET and PET/CT in recurrent head and neck cancer and clinical implications.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Comparison between PET and PET ...... cer and clinical implications.
@en
Comparison between PET and PET ...... cer and clinical implications.
@nl
type
label
Comparison between PET and PET ...... cer and clinical implications.
@en
Comparison between PET and PET ...... cer and clinical implications.
@nl
prefLabel
Comparison between PET and PET ...... cer and clinical implications.
@en
Comparison between PET and PET ...... cer and clinical implications.
@nl
P2093
P1476
Comparison between PET and PET ...... cer and clinical implications.
@en
P2093
Antoine Giovanni
David Lussato
Michel Zanaret
Nicolas Fakhry
Thierry Jacob
P2888
P304
P356
10.1007/S00405-006-0225-5
P50
P577
2007-01-04T00:00:00Z